MJ Pharmaceuticals Inc.
company.status.inactiveCIK 1502629fmd_1Q6H0MJM1HKN1MMCMFVKKQPN3PServices · Services-Business Services, NECTemplate: Standard
Coverage: Jan 01, 2012 to Jun 30, 2016, 15 periods
Latest annual · FY2013
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
Latest quarter · Q2 FY2016
Millions- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
- Free cash flow
- (0)
MJ Pharmaceuticals Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Gross profit | $0 | $3,721 | -100% | 10-K 2016-04-14 · proof |
| Net income | -$7,164 | -$13,208 | 10-K 2016-04-14 · proof | |
| Cash from operating activities | -$3,387 | $1,347 | -351.4% | 10-K 2016-04-14 · proof |
| Total assets | $3,971 | $7,358 | -46% | 10-K 2016-04-14 · proof |
| Total liabilities | $9,758 | $5,981 | +63.1% | 10-K 2016-04-14 · proof |
| Cash and cash equivalents | $3,971 | $7,358 | -46% | 10-K 2016-04-14 · proof |
- What was MJ Pharmaceuticals Inc.'s gross profit in fiscal 2015?
- MJ Pharmaceuticals Inc. reported gross profit of $0 for fiscal 2015 (the year ended Dec 31, 2015), against $3,721 the year before (-100%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What was MJ Pharmaceuticals Inc.'s net income in fiscal 2015?
- MJ Pharmaceuticals Inc. reported net income of -$7,164 for fiscal 2015 (the year ended Dec 31, 2015), against -$13,208 the year before. Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What was MJ Pharmaceuticals Inc.'s cash from operating activities in fiscal 2015?
- MJ Pharmaceuticals Inc. reported cash from operating activities of -$3,387 for fiscal 2015 (the year ended Dec 31, 2015), against $1,347 the year before (-351.4%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What are MJ Pharmaceuticals Inc.'s total assets?
- As of Dec 31, 2015, MJ Pharmaceuticals Inc. reported total assets of $3,971, against $7,358 a year earlier (-46%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What are MJ Pharmaceuticals Inc.'s total liabilities?
- As of Dec 31, 2015, MJ Pharmaceuticals Inc. reported total liabilities of $9,758, against $5,981 a year earlier (+63.1%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
- What are MJ Pharmaceuticals Inc.'s cash and cash equivalents?
- As of Dec 31, 2015, MJ Pharmaceuticals Inc. reported cash and cash equivalents of $3,971, against $7,358 a year earlier (-46%). Source: the 10-K filed with the SEC on Apr 14, 2016. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1502629&period_type=annual&limit=5"Information only, not investment advice.